TALEN

TALEN1-irx1a

ID
ZDB-TALEN-200204-1
Name
TALEN1-irx1a
Previous Names
None
Target
Target Sequence 1
5' - TCCCCCAGCTGGGCTACCCG - 3'
Target Sequence 2
5' - TCCCGGTCGGTCGCCTCCG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
zf3177 irx1a
Expression
Gene expression in Wild Types + TALEN1-irx1a
No data available
Phenotype
Phenotype resulting from TALEN1-irx1a
No data available
Phenotype of all Fish created by or utilizing TALEN1-irx1a
Phenotype Fish Conditions Figures
whole organism sterile, abnormal irx1azf3177/zf3177; irx1bzf3176/zf3176 (AB) standard conditions Fig. 1 with image from Jung et al., 2019
whole organism ccnd1 expression increased amount, abnormal irx1azf3177/zf3177; irx1bzf3176/zf3176 (AB) standard conditions Fig. 5 from Jung et al., 2019
whole organism cdkn1a expression increased amount, abnormal irx1azf3177/zf3177; irx1bzf3176/zf3176 (AB) standard conditions Fig. 5 from Jung et al., 2019
whole organism ccne1 expression increased amount, abnormal irx1azf3177/zf3177; irx1bzf3176/zf3176 (AB) standard conditions Fig. 5 from Jung et al., 2019
intestine carcinoma present, abnormal irx1azf3177/zf3177; irx1bzf3176/zf3176 (AB) standard conditions Fig. 3Fig. 4 from Jung et al., 2019
whole organism cdkn2a/b expression increased amount, abnormal irx1azf3177/zf3177; irx1bzf3176/zf3176 (AB) standard conditions Fig. 5 from Jung et al., 2019
whole organism cdkn2d expression increased amount, abnormal irx1azf3177/zf3177; irx1bzf3176/zf3176 (AB) standard conditions Fig. 5 from Jung et al., 2019
whole organism carcinoma proliferative, abnormal irx1azf3177/zf3177; irx1bzf3176/zf3176 (AB) standard conditions Fig. 4 from Jung et al., 2019
whole organism morphology, abnormal irx1azf3177/zf3177; irx1bzf3176/zf3176 (AB) standard conditions Fig. 1 with image from Jung et al., 2019
testis carcinoma present, abnormal irx1azf3177/zf3177; irx1bzf3176/zf3176 (AB) standard conditions Fig. 3 from Jung et al., 2019
pancreas carcinoma present, abnormal irx1azf3177/zf3177; irx1bzf3176/zf3176 (AB) standard conditions Fig. 4 from Jung et al., 2019
whole organism carcinoma hyperplastic, abnormal irx1azf3177/zf3177; irx1bzf3176/zf3176 (AB) standard conditions Fig. 3 from Jung et al., 2019
whole organism il6 expression increased amount, abnormal irx1azf3177/zf3177; irx1bzf3176/zf3176 (AB) standard conditions Fig. 5 from Jung et al., 2019
kidney carcinoma present, abnormal irx1azf3177/zf3177; irx1bzf3176/zf3176 (AB) standard conditions Fig. 3 from Jung et al., 2019
intrahepatic bile duct carcinoma present, abnormal irx1azf3177/zf3177; irx1bzf3176/zf3176 (AB) standard conditions Fig. 4 from Jung et al., 2019
ovary cystic, abnormal irx1azf3177/zf3177; irx1bzf3176/zf3176 (AB) standard conditions Fig. 3 from Jung et al., 2019
whole organism cdkn2c expression increased amount, abnormal irx1azf3177/zf3177; irx1bzf3176/zf3176 (AB) standard conditions Fig. 5 from Jung et al., 2019
whole organism decreased life span, abnormal irx1azf3177/zf3177; irx1bzf3176/zf3176 (AB) standard conditions Fig. 1 with image from Jung et al., 2019
Citations